AllisonDB, CaseyDE. Antipsychotic-induced weight gain: A review of the literature. J Clin Psychiatry, 62,Suppl 7:22–31. 2001.
2.
ArmanS, SadramelyMR, NadiM, KoleiniN. A randomized, double-blind, placebo-controlled trial of metformin treatment for weight gain associated with initiation of risperidone in children and adolescents. Saudi Med J, 29:1130–1134. 2008.
3.
BriffaD, MeehanT. Weight changes during clozapine treatment. Australian and New Zealand J Psychiatry, 32:718–721. 1998.
4.
BustilloJR, BuchananRW, IrishDI, BreierA. Differential effect of clozapine on weight: A controlled study. Am J Psychiatry, 153:817–819. 1996.
5.
CorrellCU. Antipsychotic use in children and adolescents: Minimizing adverse effects to maximize outcomes. J Am Acad Child Adolesc Psychiatry, 47:9–20. 2008.
6.
CorrellCU, ManuP, OlshanskiyV, NapolitanoB, KaneJM, MalhotraAK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA, 302:1765–1773. 2009.
7.
FleischhakerC, HeiserP, HennighausenK, Herpertz-DahlmannB, HoltkampK, Mehler-WexC, RauhR, RemschmidtH, SchulzE, WarnkeA. Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone. J Neural Transm, 115:1599–1608. 2008.
8.
GogtayN, RapoportJ. Clozapine use in children and adolescents. Expert Opin Pharmacother, 9:459–465. 2008.
9.
HaddadPM, SharmaSG. Adverse effects of atypical antipsychotics: Differential risk and clinical implications. CNS Drugs, 21:911–936. 2007.
10.
HendersonDC, CaglieroE, GrayC, NasrallahRA, HaydenDL, SchoenfeldDA, GoffDC. Clozapine, diabetes mellitus, weight gain and lipid abnormalitites: A five-year naturalistic study. Am J Psychiatry, 157:975–981. 2000.
11.
KeskinM, KurtogluS, KendirciM, AtabekME, YaziciC. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics, 115:500–503. 2005.
12.
KleinDJ, CottinghamEM, SorterM, BartonBA, MorrisonJA. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents. Am J Psychiatry, 163:2072–2079. 2006.
ShinL, BregmanH, BreezeJL, NoyesN, FrazierJA. Metformin for weight control in pediatric patients on atypical antipsychotic medication. J Child Adolesc Psychopharmacol, 19:275–279. 2009.
18.
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 26:3160–3167. 2003.
